'Fast Money' Recap: Looking for High-Growth Investment Opportunities

NEW YORK (TheStreet) -- The S&P 500 finished slightly lower on the day, down 0.02%. 

On CNBC's "Fast Money" TV show, the trading panel looked at high-growth companies on location at the Exponential Finance Conference in New York City. 

Guy Adami, managing director of stockmonster.com, said investors can buy shares of Google (GOOGL), which are not very expensive in valuation. He added International Business Machine (IBM) seems poised to underperform the market. 

Steve Grasso, director of institutional sales at Stuart Frankel, is also a buyer of Google, saying its investments in robotics, self-driving cars and Wi-Fi drones, among other things, will position the company to succeed over the long term.

Adami said Facebook (FB) reported a solid earnings report last quarter, but shares sold off due with other momentum stocks. He thinks shares are poised to run to $75. 

Grasso added that shares of Twitter (TWTR) have been trading well lately too. He is looking for the stock to breakout over resistance at $37. 

Adami said he's "starting to come around" to the bull case in chip stocks. Specifically, he was referring to Intel (INTC), Advanced Micro Devices (AMD) and Analog Devices (ADI). 

Grasso admitted that he thought Intel was a "boring" company but acknowledged its potential in wearable devices in the future. 

Peter Diamandis, co-founder and executive chairman of Singularity University, was a guest on the show. He is focused on rapidly growing companies in several industries including 3-D printing, robotics, artificial intelligence and sensors. If Fortune 500 companies aren't trying to "disrupt" themselves, some other company will, he reasoned. 

Jeffrey Gundlach, founder of Doubleline Capital, said the 10-year Treasury yield will be in the range of 2.20% to 2.80% for the second half of 2014. Brian Kelly, founder of Brian Kelly Capital, said that range suggests  the current yield will fall over the next several months.

"People have been caught flat-footed by fixed-income this year" and can again in the second half, he said, especially if the U.S. is stuck in a low-growth environment. 

Tim Seymour, managing partner of Triogem Asset Management, said investors have been "poorly positioned" with the expectation that yields were going to increase in 2014 so far. However, he argued that the U.S. economy is doing pretty good and that yields will eventually head higher because of this, not lower. 

Time (TIME) is reportedly in advanced talks to acquire a stake in Vice Media, which would value Vice at roughly $2.2 billion. Dan Nathan, co-founder and editor of riskreversal.com, said the valuation of Vice is likely to continue moving higher after this deal because it has successfully built a "great business model."

Sony (SNE) announced its Playstation TV on Wednesday. Seymour said that it's exciting news, although the technology has been around for a while and it will pit Sony against Microsoft (MSFT). He added that Sony may struggle after the next six to nine months but seems to have a bottom near $16. 

Las Vegas Sands (LVS) was downgraded by UBS to hold from buy. Kelly said the slowing revenue from Macau will likely weigh on the company's results. It's "going to be challenged for a while," he added. 

Nathan pointed out that 75% of Wynn Resorts' (WYNN) profits come from Macau, and a slowdown in the region will certainly hurt the company.  He "wouldn't touch it." 

CNBC's Meg Tirrell was a guest on the show to discuss some up-and-coming products and companies in the health care technology space. Covidien (COV) bought Given Imaging for $860 million 2013. The company now has a device that allows patients to ingest a "camera pill" that takes photos of the digestive tract. It could perhaps eliminate the colonoscopy. 

Other companies, such as Sanofi (SNY) and Illumina  (ILMN) are creating mobile applications that can benefit both patients and doctors. GlaxoSmithKline (GSK) is also working on what it called Electroceuticals, which is where rice-sized electrical devices attach to patients' nerves. The treatment may help treat diabetes, obesity and hypertension but is likely 10 years away from becoming reality. 

Adami said Covidien is not an earnings or valuation play, it's an investment in the future. It still make sense to own despite the recent run-up in the share price, he urged. 

Nathan liked shares of GlaxoSmithKline, which are 5% from the all-time highs. Technically, the stock looks great, he said, along with a solid dividend yield of 4.8%. 

Avi Reichental, president and CEO of 3D Systems (DDD), was a guest on the show. He said the company recently raised revenue estimates (but not earnings per share estimates) due to higher demand from the health care and manufacturing industries.

He added the company is introducing 24 new products this year, which will "temporarily pressure" margins. Reichental concluded by saying he's open to partnerships with other companies, and suggested that the barriers to entry in the industry are quite "substantial." 

Kelly called bitcoin "more than just a new currency and it's more than a payment system." It has a big future, he added. Seymour said the volatility in bitcoin prices are lower, which Adami attributed to a higher acceptance rate among the general public. Adami said the price can continue moving higher for now. 

Keurig Green Mountain (GMCR) climbed 1% and was the first stock on the show's "Pops & Drops" segment. Kelly said he would take profits in the stock. 

AthenaHealth (ATHN) fell 3%. Adami is a seller, saying the stock "goes lower from here." 

Anheuser-Busch (BUD) jumped 3%. Seymour said the company continues to benefit from cost cutting and global growth.

Ed Maguire, managing director at CLSA, was a guest on the show. Regarding cyber security, his top three picks included FireEye (FEYE), Palo Alto Networks (PANW) and Splunk (SPLK), and he has an $80 price target on Splunk. Cyber attacks are human-created problems so it's only likely to get worse going forward, he said. 

Kelly said he loves the cyber security industry but he will likely never buy shares of FireEye unless there is a management change. Grasso pointed out that Intel has been involved in cyber security, via its acquisition in McAfee, but it "hasn't moved the needle much" for the company. 

Nathan pointed out the bullish options activity in shares of Lululemon Athletica (LULU), specifically in the July $50 call options. He added that the stock seems oversold near current levels. 

For their final trades, Seymour was a buyer of Citigroup (C) and Adami was buying Facebook. 

-- Written by Bret Kenwell in Petoskey, Mich.

Follow @BretKenwell

Follow TheStreet.com on Twitter and become a fan on Facebook.


Bret Kenwell currently writes, blogs and also contributes to Robert Weinstein's Weekly Options Newsletter.

More from Jim Cramer

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

First Horizon National: Cramer's Top Takeaways

First Horizon National: Cramer's Top Takeaways

Waste Management: Cramer's Top Takeaways

Waste Management: Cramer's Top Takeaways

Jim Cramer: Will Apple or Amazon Become the World's First Trillion Dollar Stock?

Jim Cramer: Will Apple or Amazon Become the World's First Trillion Dollar Stock?

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)